-transparent.png){kind=logo}
We used the nationwide Swedish Family-Cancer Database to analyze the risk for central nervous system hemangioblastoma (HB) in offspring (0-61 years) of parents with cancer. Eighty-three offspring were identified, and the age at onset showed a bimodal distribution. The early-onset component peaked at 25-29 years, was associated with von Hippel-Lindau (VHL) disease and presented with HBs, renal cell carcinomas, pheochromocytomas and insulomas in the proband or other family members. Standardized incidence ratios (SIRs) were 600 for offspring HB by parental HB, and they were even high for the other VHL-related tumors. Second tumors were common in this early-onset group, and the types were as expected in VHL. The late-onset component peaked at 40-44 years, and it was twice as prevalent as the early-onset component. Because there was no evidence of familial risks, this is suggested to be a sporadic form of HB.
K Hemminki, and
X Li, and
V P Collins
January 2003,
Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko,
K Hemminki, and
X Li, and
V P Collins
January 1984,
European archives of psychiatry and neurological sciences,
K Hemminki, and
X Li, and
V P Collins
August 1997,
Medical and pediatric oncology,
K Hemminki, and
X Li, and
V P Collins
October 1993,
Ugeskrift for laeger,
K Hemminki, and
X Li, and
V P Collins
June 1990,
Neurologia medico-chirurgica,
K Hemminki, and
X Li, and
V P Collins
June 2015,
World neurosurgery,
K Hemminki, and
X Li, and
V P Collins
August 1958,
Zentralblatt fur allgemeine Pathologie u. pathologische Anatomie,
K Hemminki, and
X Li, and
V P Collins
August 2010,
Acta neurologica Scandinavica,
K Hemminki, and
X Li, and
V P Collins
December 1973,
Minnesota medicine,
K Hemminki, and
X Li, and
V P Collins
December 2020,
Clinical neurology and neurosurgery,
